Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-27 @ 7:02 AM
Study NCT ID:
NCT06181734
Status:
COMPLETED
Last Update Posted:
2025-12-09
First Post:
2023-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC
Sponsor:
iOMEDICO AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2023-11-27
First Submit QC Date:
None
Study First Post Date:
2023-12-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-09
Last Update Post Date Type:
ESTIMATED